A protein roadmap to pluripotency and faithful reprogramming
Abstract
Embryonic stem (ES) cells are of great interest because of their capability of unlimited self-renewal and multilineage differentiation, thus serving as a potentially unlimited source for tissue replacement in regenerative medicine. ES cells possess factors that maintain and induce pluripotency, as demonstrated by successful reprogramming of somatic cells by fusion with ES cells. Understanding the complex molecular mechanisms underlying ES cell pluripotency should illuminate fundamental properties of stem cells and the process of reprogramming. Proteomics has proven to be a powerful approach to gain insight into key intracellular signals governing ES cell self-renewal and differentiation. We have recently employed a proteomics approach to explore the regulatory protein networks in which Nanog, a fundamental ES cell transcription factor, operates and have constructed the first protein interaction network in mouse ES cells. The network is highly enriched for factors known to be critical in ES cell biology and appears to function as a module for pluripotency. Here we will review current ES cell proteomic studies and provide insights into how a pluripotency protein network will advance recent efforts in cellular reprogramming.
References
Chicken "erythroid" cells transformed by the Gag-Myb-Ets-encoding E26 leukemia virus are multipotent
Citations
Related Concepts
Related Feeds
Adult Stem Cells
Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.
Allogenic & Autologous Therapies
Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.